Add the group’s latest paper or preprint
This card is ready for a short research highlight and a link to the publication.
Content placeholderGurnani Group
We develop non-viral delivery systems from the molecule up—connecting chemistry, formulation and nanoscale assembly to create better medicines.
Delivery is a molecular design problem. We study how chemical structure and formulation choices govern assembly, stability and biological performance.
Research themes
From molecular architecture
to medicines.
01
PEG-alternative surfaces
Developing new approaches to nanoparticle surface engineering that move beyond conventional PEGylation.
↗︎
02
Immunoactive delivery systems
Designing delivery materials that engage, direct or temper immune responses alongside nucleic acid cargo.
↗︎
03
Targeted delivery
Controlling where nucleic acid medicines go through ligand design, surface architecture and formulation strategy.
↗︎
04
Advanced characterisation
Building deeper structure–property relationships with analytical methods that resolve complex delivery systems.
↗︎
Latest news
From the group.
Share an award, talk or collaboration
Use this space for the people and partnerships moving the group’s research forward.
Content placeholderShow a formulation milestone
Explain a new method or result in clear language for collaborators and the wider public.
Content placeholder